Canakinumab for the Treatment of Children With Colchicine‐Resistant Familial Mediterranean Fever: A 6‐Month Open‐Label, Single‐Arm Pilot Study

Publisher: John Wiley & Sons Inc

E-ISSN: 2326-5205|66|11|3241-3243

ISSN: 2326-5191

Source: ARTHRITIS & RHEUMATOLOGY, Vol.66, Iss.11, 2014-11, pp. : 3241-3243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content